SCHEMBL836614

SCHEMBL836614

CC(NC(=O)OC(C)(C)C)C(=O)c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.44
HTT P42858 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
POLB P06746 2/20 0.42
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRB3 P13945 2/20 0.41
ATM Q13315 2/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
EPHX2 P34913 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CES2 O00748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836615 1.00 TRPA1 (0.44) TRPA1HTTKDM4EALDH1A1HPGD
SCHEMBL16256023 0.87 HPGD (0.41) TRPA1HTTKDM4EALDH1A1HPGD
SCHEMBL2762824 0.83 GAA (0.53) TRPA1HTTKDM4EALDH1A1HPGD
SCHEMBL15081462 0.83 CTSS (0.46) TRPA1HTTALDH1A1POLBADRB2
SCHEMBL16255881 0.82 POLB (0.46) HTTKDM4EALDH1A1HPGDPOLB
SCHEMBL15632170 0.82 HPGD (0.48) ALDH1A1HPGDCTSSCTSKNPC1
SCHEMBL28812115 0.82 HPGD (0.48) ALDH1A1HPGDCTSSCTSKNPC1
SCHEMBL30695659 0.81 LMNA (0.49) HTTPOLBATMCTSSCTSK
SCHEMBL9805646 0.79 POLB (0.45) HTTKDM4EALDH1A1HPGDPOLB
SCHEMBL23619006 0.79 PPARA (0.48) ATMCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120252770-A1 Chemical Compounds 572 BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-10-04 US disclosed
EP-2102169-B1 INDAZOLYL AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2012-06-20 EP disclosed
US-8143290-B2 Chemical compounds 572 ASTRAZENECA AB (SE) 2012-03-27 US disclosed
US-20110071194-A1 Chemical Compounds 572 BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-24 US disclosed
US-20100197644-A1 Chemical Compounds 572 BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-05 US disclosed
US-7728030-B2 Chemical compounds 572 ASTRAZENECA AB (SE) 2010-06-01 US disclosed
US-20080214641-A1 Chemical compounds 572 BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214641-A1 Chemical compounds 572 ABCG2, ABCB1, CYP11B2 TRPA1 880/4885HTT 4179/4885KDM4E 2848/4885
US-20100197644-A1 Chemical Compounds 572 ABCG2, ABCB1, CYP11B2 TRPA1 880/4885HTT 4179/4885KDM4E 2848/4885
US-20120252770-A1 Chemical Compounds 572 ABCG2, ABCB1, CYP11B2 TRPA1 880/4885HTT 4179/4885KDM4E 2848/4885
US-20110071194-A1 Chemical Compounds 572 ABCG2, ABCB1, CYP11B2 TRPA1 880/4885HTT 4179/4885KDM4E 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.